SABS
SAB Biotherapeutics Inc
NASDAQ: SABS · HEALTHCARE · BIOTECHNOLOGY
$3.74
+7.47% today
Updated 2026-04-30
Market cap
$248.07M
P/E ratio
—
P/S ratio
2.96x
EPS (TTM)
$-0.79
Dividend yield
—
52W range
$2 – $5
Volume
0.6M
SAB Biotherapeutics Inc (SABS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-92.3%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+58.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+6.8%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+12.9%
2025-11-14
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-26 | $-0.41 | -142.1% | $3.82 | $3.85 | +0.8% |
| 2025-11-14 | $-0.21 | -75.0% | $3.10 | $3.50 | +12.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.17 | $-0.41 | -142.1% | — | — |
| 2025-09-30 | $-0.12 | $-0.21 | -75.0% | — | — |
| 2025-06-30 | $-0.11 | $-1.09 | -890.9% | — | — |
| 2025-03-31 | $-1.07 | $-0.56 | +47.8% | — | — |
| 2024-12-31 | $-1.21 | $-0.98 | +18.9% | $114698.00 | -62.4% |
| 2024-09-30 | $-1.09 | $-1.12 | -2.8% | $-410.00 | -100.0% |
| 2024-06-30 | $-1.13 | $-0.79 | +30.1% | $263137.00 | +207.7% |
| 2024-03-31 | $-0.96 | $-0.54 | +43.7% | $944575.00 | +62.5% |
| 2023-12-31 | $-0.62 | $-3.38 | -445.2% | $305011.00 | — |
| 2023-09-30 | $-0.12 | $-0.10 | +16.7% | $1.27M | — |
| 2023-06-30 | $-0.14 | $-0.14 | +0.0% | $85518.00 | — |
| 2023-03-31 | $-0.08 | $-0.15 | -87.5% | $581101.00 | — |
Frequently asked questions
Has SAB Biotherapeutics Inc beaten earnings estimates?
SAB Biotherapeutics Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -92.3% over the last 4 quarters.
How does SABS stock react to earnings?
SABS stock has moved an average of +6.8% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.